Macrogenics MGNX
NASDAQ MGNX
$4.40 +0.15 (+3.53%)
At close: Sep 4, 2026 · 4:00 PM EDT

Macrogenics (MGNX) Other Working Capital Changes (2018 - 2026)

Macrogenics (MGNX) posted quarterly Other Working Capital Changes of -$324000.0 for Q1 2026, down 6580.0% year-over-year from $5000.0 in Q1 2025, and down 214.89% quarter-over-quarter from $282000.0 in Q4 2025.

Analysis

Macrogenics (MGNX) Other Working Capital Changes (2018 - 2026) Analysis & Trends

Macrogenics (MGNX) has reported Other Working Capital Changes for 9 consecutive years, with -$324000.0 the latest figure, recorded in Q1 2026.

  • In Q1 2026, Other Working Capital Changes fell 6580.0% year-over-year to -$324000.0; the TTM figure through Mar 2026 stood at -$5.7 million (up 23.98% YoY), while the FY2025 annual figure was -$5.4 million, up 42.66% from the prior year.
  • Other Working Capital Changes slipped to -$324000.0 in Q1 2026 per MGNX's latest filing, from $282000.0 in the prior quarter.
  • Across five years, Other Working Capital Changes topped out at $14.0 million in Q4 2022 and bottomed at -$6.5 million in Q1 2022.
  • Historically, Other Working Capital Changes has averaged $989142.9 across 5 years, with a median of -$70500.0 in 2024.
  • Annual changes were most pronounced in 2022 — Other Working Capital Changes jumped 1751.54% — and 2026, when it plunged 6580.0%.
  • Macrogenics' Other Working Capital Changes stood at $57.3 million in 2022, then plunged by 78.8% to $12.1 million in 2023, then tumbled by 178.54% to -$9.5 million in 2024, then soared by 102.96% to $282000.0 in 2025, then sank by 214.89% to -$324000.0 in 2026.
  • Business Quant data shows MGNX's Other Working Capital Changes at -$324000.0 in Q1 2026, $282000.0 in Q4 2025, and -$5.5 million in Q3 2025.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Vertex Pharmaceuticals 138.47 Bn 130.62 Bn 2.84 Bn
2 Regeneron Pharmaceuticals 85.18 Bn 77.19 Bn 3.93 Bn
3 Argenx Se 63.38 Bn 58.19 Bn 1.37 Bn
4 Moderna 58.09 Bn 52.95 Bn 52.00 Mn
5 Revolution Medicines 44.33 Bn 44.33 Bn -
6 BeOne Medicines 40.02 Bn 34.92 Bn 1.53 Bn
7 Alnylam Pharmaceuticals 35.57 Bn 32.27 Bn 992.69 Mn
8 Royalty Pharma 28.45 Bn 27.61 Bn -
9 Insmed 27.48 Bn 26.32 Bn 358.27 Mn
10 Macrogenics 284.90 Mn 171.00 Mn -
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 -4.30 Mn
Jun 30, 2026 -4.30 Mn
Mar 31, 2026 1.57 Mn
Mar 31, 2026 1.57 Mn
Dec 31, 2025 282,000.00
Dec 31, 2025 282,000.00
Sep 30, 2025 2.53 Mn
Sep 30, 2025 2.53 Mn
Jun 30, 2025 -7.94 Mn
Jun 30, 2025 -7.94 Mn
Mar 31, 2025 -264,000.00
Mar 31, 2025 -264,000.00
Dec 31, 2024 -7.33 Mn
Dec 31, 2024 -7.33 Mn
Sep 30, 2024 -511,000.00
Sep 30, 2024 -511,000.00
Jun 30, 2024 302,000.00
Jun 30, 2024 302,000.00
Mar 31, 2024 -1.88 Mn
Mar 31, 2024 -1.88 Mn